Thomas X - Search Results

1

Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.

Reman O, Buzyn A, Lhéritier V, Huguet F, Kuentz M, Stamatoullas A, Delannoy A, Fegueux N, Micléa JM, Boiron JM, Vernant JP, Gardin C, Hacini M, Georges M, Fière D, Thomas X; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte. Reman O, et al. Among authors: thomas x. Hematol J. 2004;5(2):123-9. doi: 10.1038/sj.thj.6200353. Hematol J. 2004. PMID: 15048062 Clinical Trial.

2

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Archimbaud E, Thomas X, Campos L, Magaud JP, Doré JF, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Apr;6(4):265-71. Leukemia. 1992. PMID: 1375302

3

Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.

Archimbaud E, Thomas X, Campos L, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leuk Res. 1992 Jun-Jul;16(6-7):673-80. doi: 10.1016/0145-2126(92)90018-3. Leuk Res. 1992. PMID: 1378919

4

Surface marker expression in acute myeloid leukaemia at first relapse.

Thomas X, Campos L, Archimbaud E, Shi ZH, Treille-Ritouet D, Anglaret B, Fiere D. Thomas X, et al. Br J Haematol. 1992 May;81(1):40-4. doi: 10.1111/j.1365-2141.1992.tb08168.x. Br J Haematol. 1992. PMID: 1381608

5

Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission.

Archimbaud E, Anglaret B, Thomas X, Jaubert J, Sebban C, Guyotat D, Fiere D. Archimbaud E, et al. Among authors: thomas x. Ann Hematol. 1992 Aug;65(2):71-4. doi: 10.1007/BF01698132. Ann Hematol. 1992. PMID: 1511060 Clinical Trial.

6

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

7

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

8

Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.

Salles G, Archimbaud E, Thomas X, Fiere D. Salles G, et al. Among authors: thomas x. Cancer Chemother Pharmacol. 1991;28(1):77-9. doi: 10.1007/BF00684962. Cancer Chemother Pharmacol. 1991. PMID: 2040038 Clinical Trial.

9

Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns.

Guyotat D, Campos L, Thomas X, Vila L, Shi ZH, Charrin C, Gentilhomme O, Fiere D. Guyotat D, et al. Among authors: thomas x. Am J Hematol. 1990 May;34(1):26-31. doi: 10.1002/ajh.2830340107. Am J Hematol. 1990. PMID: 2327401

10

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.

Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. Thomas X, et al. Leukemia. 1995 Feb;9(2):249-53. Leukemia. 1995. PMID: 7532767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page